While I am still calculating with high growth rates in the next five years, we should point out that these assumptions are in ...

DexCom, Inc. DXCM reported second-quarter 2026 adjusted earnings per share (EPS) of 70 cents, which beat the Zacks Consensus ...

Shares of DexCom (DXCM) have been strong performers lately, with the stock up 17.1% over the past month. The stock hit a new 52-week high of $84.7 in the previous session. DexCom has gained 25.7% ...

DexCom (DXCM) delivered earnings and revenue surprises of +14.75% and +1.01%, respectively, for the quarter ended June 2026.

DexCom (NASDAQ:DXCM) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a snapshot of their recent ratings, ...

In this week's earnings recap, nine companies reported results, with eight beating EPS expectations, while Universal Health Services ( UHS) missed estimates. On the revenue front, all nine companies ...

Dexcom’s G6 continuous glucose monitoring system will now be available at no cost for qualifying veterans through all U.S. Department of Veterans Affairs pharmacies, the company announced Tuesday. To ...

The Non-Insured Health Benefits (NIHB) program establishes exemplary coverage for Dexcom’s real-time continuous glucose monitoring system – bringing game-changing technology to more First Nations and ...

DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the continuous glucose monitoring (CGM) market. A strong first-quarter 2026 ...